{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:44:37Z","timestamp":1791247477136,"version":"4.1.0"},"reference-count":31,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2018,12,14]]},"abstract":"<jats:sec><jats:title\/><jats:p>Introduction: Apolipoprotein E4 (ApoE) is a major genetic factor for developing Alzheimer\u2019s disease (AD). It plays a vital role in brain to maintain a constant supply of neuronal lipids for rapid and dynamic membrane synthesis. Aggregation of beta amyloid plaques (A&amp;#946;) and neurofibrillary tangles in brain are responsible for onset of AD. The current study is designed to predict a drug against over activity of apoE4. 22 natural compounds (marine, microorganism and plant derivative) were used in current study. &lt;\/P&gt;&lt;P&gt; Methods: These compounds were used as inhibitors to target apoE4 protein activity. Moreover, six synthetic compounds were docked with target protein to compare and analyze the docking results with natural compounds. S-Allyl-L-Cysteine, Epicatechin Gallate and Fulvic acid showed highest binding affinity (-7.1, - 7 and -7 kcal \/mol respectively). Analysis of the docked complex showed that Epicatechin Gallate bonded with Gln156 and Asp35. Furthermore, Fulvic Acid showed hydrogen bonding with Glu27. Among synthetic compound, Tideglusib had highest binding affinity with target protein but did not show hydrogen bonding with any amino acid residue. Moreover, a natural compound S-Allyl-LCysteine also showed highest binding affinity but did not show hydrogen bonding with any amino acid residue. &lt;\/P&gt;&lt;P&gt; Results and Conclusion: Our study highlighted Epicatechin Gallate as a potential lead compound on the basis of binding affinity and hydrogen bonding to inhibit the progression of AD.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573409914666181008164209","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T11:33:29Z","timestamp":1539257609000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["In Silico Identification of Novel Apolipoprotein E4 Inhibitor for Alzheimer\u2019s Disease Therapy"],"prefix":"10.2174","volume":"15","author":[{"given":"Saddia","family":"Bano","sequence":"first","affiliation":[{"name":"Research Center for Modelling and Simulations, National University of Sciences and Technology Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asif","family":"Rasheed","sequence":"additional","affiliation":[{"name":"Department of Biosciences, COMSATS University Islamabad, Sahiwal Campus, Sahiwal, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrukh","family":"Jamil","sequence":"additional","affiliation":[{"name":"Department of Biosciences, COMSATS University Islamabad, Sahiwal Campus, Sahiwal, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Biosciences, COMSATS University Islamabad, Sahiwal Campus, Sahiwal, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaira","family":"Kanwal","sequence":"additional","affiliation":[{"name":"Department of Biosciences, COMSATS University Islamabad, Sahiwal Campus, Sahiwal, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"Wimo A.","year":"","unstructured":"Wimo A, J\u00f6nsson L, Bond J, Prince M, Winblad B. The worldwide economic impact of dementia 2010. Alzheimers Dement., (N Y), 2013, 9(1), 1-11. e3., , ,","journal-title":"The worldwide economic impact of dementia 2010 Alzheimers Dement, (N Y), 2013, 9(1), 1-11 e3"},{"key":"ref=2","author":"Huang H.-J.","year":"2014 2014","unstructured":"Huang H-J, Chen H-Y, Lee C-C, Chen CY-C. Computational design of apolipoprotein E4 inhibitors for Alzheimer\u2019s disease therapy from traditional Chinese medicine.BioMed Res. Int, , , 2014 2014","journal-title":"Computational design of apolipoprotein E4 inhibitors for Alzheimer\u2019s disease therapy from traditional Chinese medicineBioMed Res Int"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"Corder E.H.","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small G, Roses AD, Haines J, Pericak-Vance MA. Science, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families.,, 1993, 261,, 921-923,","journal-title":"Science"},{"key":"ref=4","first-page":"1034","volume":"48","author":"Pericak-Vance M.","year":"1991","unstructured":"Pericak-Vance M, Bebout J, Gaskell P, Yamaoka L, Hung W-Y, Alberts M, Walker A, Bartlett R, Haynes C, Welsh K. Am Journa Hum Genet, Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.,, 1991, 48,, 1034-,","journal-title":"Am Journa Hum Genet"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2013.12.016","volume":"64","author":"Johnson L.A.","year":"2014","unstructured":"Johnson LA, Olsen RH, Merkens LS, DeBarber A, Steiner RD, Sullivan PM, Maeda N, Raber J. Neurobiol Dis, Apolipoprotein E\u2013low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.,, 2014, 64,, 150-162,","journal-title":"Neurobiol Dis"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"Strittmatter W.J.","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD, Apolipoprotein E. Proc Natl Acad Sci, High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.,, 1993, 90,, 1977-1981,","journal-title":"Proc Natl Acad Sci"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1749-6632.1998.tb10653.x","volume":"855","author":"Roses A.D.","year":"1998","unstructured":"Roses AD. Ann N Y Acad Sci, Apolipoprotein E and Alzheimer\u2019s disease: The tip of the susceptibility iceberg.,, 1998, 855,, 738-743,","journal-title":"Ann N Y Acad Sci"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(10)70306-9","volume":"10","author":"van der Flier W.M.","year":"2011","unstructured":"van der Flier WM, Pijnenburg YA, Fox NC, Scheltens P. Lancet The Neurol, Early-onset versus late-onset Alzheimer\u2019s disease: the case of the missing APOE \u025b4 allele.,, 2011, 10,, 280-288,","journal-title":"Lancet The Neurol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"22358","DOI":"10.1016\/S0021-9258(17)31797-0","volume":"269","author":"Dong L-M.","year":"1994","unstructured":"Dong L-M, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, Agard DA. J Biol Chem, Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.,, 1994, 269,, 22358-22365,","journal-title":"J Biol Chem"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"Tanzi R.E.","year":"2005","unstructured":"Tanzi RE, Bertram L. Cell, Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: A genetic perspective.,, 2005, 120,, 545-555,","journal-title":"Cell"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","volume":"6","author":"Risner M.","year":"2006","unstructured":"Risner M, Saunders A, Altman J, Ormandy G, Craft S, Foley I, Zvartau-Hind M, Hosford D, Roses A. The Pharmaco J, Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer\u2019s disease.,, 2006, 6,, 246-,","journal-title":"The Pharmaco J"},{"key":"ref=12","first-page":"5066","volume":"4","author":"Kalita P.","year":"2014","unstructured":"Kalita P, Sarma R, Parida P, Kiranmai C, Barthakur M, Reddy PVB. Indo Am J Pharma Res, in silico modelling and structural characterization of \u03b3-aminobutyrate aminotransferase (GABA-AT).,, 2014, 4,, 5066-5073,","journal-title":"Indo Am J Pharma Res"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.drudis.2006.02.008","volume":"11","author":"Stahl M.","year":"2006","unstructured":"Stahl M, Guba W, Kansy M. Drug Discov Today, Integrating molecular design resources within modern drug discovery research: The Roche experience.,, 2006, 11,, 326-333,","journal-title":"Drug Discov Today"},{"key":"ref=14","first-page":"8","volume":"21","author":"Conway E.L.","year":"1998","unstructured":"Conway EL. Clin Neuropharmacol, A review of the randomized controlled trials of tacrine in the treatment of Alzheimer\u2019s disease: Methodologic considerations.,, 1998, 21,, 8-17,","journal-title":"Clin Neuropharmacol"},{"key":"ref=15","author":"","unstructured":", , ,Mayeux, R.; Sano, M., Treatment of Alzheimer's disease. New Eng. J. Med., 1999, 341(22), 1670-1679; (b) Weisgraber, K.H. Apolipoprotein E: Structure-function relationships. In Advances in protein chemistry, Elsevier: 1994; Vol. 45, pp 249-302; (c) Calcul, L.; Zhang, B.; Jinwal, U.K.; Dickey, C.A.; Baker, B.J. Natural products as a rich source of tau-targeting drugs for Alzheimer\u2019s disease. Fut. Med. Chem., 2012, 4(13), 1751-1761, , , , ,-"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/pro.3331","volume":"27","author":"Burley S.K.","year":"2018","unstructured":"Burley SK, Berman HM, Christie C, Duarte JM, Feng Z, Westbrook J, Young J, Zardecki C. Protein Sci, RCSB Protein Data Bank: Sustaining a living digital data resource that enables breakthroughs in scientific research and biomedical education.,, 2018, 27,, 316-330,","journal-title":"Protein Sci"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","volume":"50","author":"Lovell S.C.","year":"2003","unstructured":"Lovell SC, Davis IW, Arendall WB, De Bakker PI, Word JM, Prisant MG, Richardson JS, Richardson DC. Proteins Structure, Function, and Bioinformatics,, Structure validation by C\u03b1 geometry: \u03d5, \u03c8 and C\u03b2 deviation.,, 2003, 50,, 437-450,","journal-title":"Proteins Structure, Function, and Bioinformatics,"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd.2017.155","volume":"16","author":"Li C.","year":"2017","unstructured":"Li C, Gotz J. Nature reviews Drug Discov, Tau-based therapies in neurodegeneration: opportunities and challenges.,, 2017, 16,, 863-883,","journal-title":"Nature reviews Drug Discov"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"Kim S.","year":"2015","unstructured":"Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA. Nucleic Acids Res, PubChem substance and compound databases.,, 2015, 44,, D1202-D1213,","journal-title":"Nucleic Acids Res"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O, Olson AJ. J Comput Chem, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.,, 2010, 31,, 455-461,","journal-title":"J Comput Chem"},{"key":"ref=21","author":"Cheng F.","unstructured":"Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW, Tang Y, admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. ACS Publications:2012, ,, , , , ,-"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2174\/092986607781483912","volume":"14","author":"Gopalakrishnan K.","year":"2007","unstructured":"Gopalakrishnan K, Sowmiya G, Sheik S, Sekar K. Protein Pept Lett, Ramachandran plot on the web (2.0).,, 2007, 14,, 669-671,","journal-title":"Protein Pept Lett"},{"key":"ref=23","author":"Desiraju G.R.","unstructured":"Desiraju GR, Steiner T, , International Union of Crystal,, , , The weak hydrogen bond: in structural chemistry and biology., 2001,-","journal-title":"The weak hydrogen bond: in structural chemistry and biology"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/prot.21253","volume":"67","author":"Panigrahi S.K.","year":"2007","unstructured":"Panigrahi SK, Desiraju GR. Proteins Structure, Function, and Bioinformatics,, Strong and weak hydrogen bonds in the protein\u2013ligand interface.,, 2007, 67,, 128-141,","journal-title":"Proteins Structure, Function, and Bioinformatics,"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"13720","DOI":"10.1021\/jacs.7b05012","volume":"139","author":"Ahmed R.","year":"2017","unstructured":"Ahmed R, VanSchouwen B, Jafari N, Ni X, Ortega J, Melacini G. J Am Chem Soc, Molecular Mechanism for the (\u2212)-Epigallocatechin Gallate-Induced Toxic to Nontoxic Remodeling of A\u03b2 Oligomers.,, 2017, 139,, 13720-13734,","journal-title":"J Am Chem Soc"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3389\/fphar.2017.00834","volume":"8","author":"Jia J-J.","year":"2017","unstructured":"Jia J-J, Zeng X-S, Song X-Q, Zhang P-P, Chen L. Frontiers in Pharmacol, Diabetes Mellitus and Alzheimer\u2019s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models.,, 2017, 8,, 834-,","journal-title":"Frontiers in Pharmacol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13027-017-0145-6","volume":"12","author":"Cascella M.","year":"2017","unstructured":"Cascella M, Bimonte S, Muzio MR, Schiavone V, Cuomo A. Infect Agent Cancer, The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer\u2019s disease: An overview of pre-clinical studies and translational perspectives in clinical practice.,, 2017, 12,, 36-,","journal-title":"Infect Agent Cancer"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-2008-15207","volume":"15","author":"Mandel S.A.","year":"2008","unstructured":"Mandel SA, Amit T, Kalfon L, Reznichenko L, Weinreb O, Youdim MB. JAD, Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J. Alzheimer\u2019s Dis.,, 2008, 15,, 211-222,","journal-title":"JAD"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbr.2012.08.039","volume":"236","author":"Biasibetti R.","year":"2013","unstructured":"Biasibetti R, Tramontina AC, Costa AP, Dutra MF, Quincozes-Santos A, Nardin P, Bernardi CL, Wartchow KM, Lunardi PS, Goncalves CA. Behav Brain Res, Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia.,, 2013, 236,, 186-193,","journal-title":"Behav Brain Res"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/ci100104j","volume":"50","author":"Shen J.","year":"2010","unstructured":"Shen J, Cheng F, Xu Y, Li W, Tang Y. J Chem Inf Model, Estimation of ADME properties with substructure pattern recognition.,, 2010, 50,, 1034-1041,","journal-title":"J Chem Inf Model"},{"key":"ref=31","author":"Szklarczyk D.","year":"","unstructured":"Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P. , The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res.,2010, 39(suppl_1), D561-D568., ,"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T07:28:50Z","timestamp":1720682930000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166057\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409914666181008164209","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}